23rd August 2018 –SENSIUM recently asked to join a consortium that intends to improve the care provided to heart failure patients by monitoring them more closely in their own homes.
Development and validation of promising integrated eHealth applications combined with nanotechnology for hospitalisation of heart failure patients at home.
What problem is NWE-Chance solving?
Cost-wise, 1-2% of total healthcare expenditure is currently associated with heart failure, of which one-half is due to people’s hospitalisation. Greater focus therefore has to be on helping people to get home and preventing them from ending up in hospital in the first place.
Despite new opportunities for home hospitalisation, it faces two main challenges. The first is the limited uptake of the idea by healthcare professionals. The second is the very few connections between the health sector and small- and medium-sized enterprises (SMEs) that are developing eHealth tools for dedicated hospital care in the home setting.
What is NWE-Chance about?
NWE-Chance is an Interreg project, based in north-west Europe (NWE). It works on delivering hospital-level care at home for heart failure patients. It is all about bringing stakeholders together to co-create the knowledge needed to get innovation in home hospitalisation to happen in the north and west of Europe.
The project contributes to develop the capabilities of SMEs and get them more involved in cooperative projects in the NWE Interreg region.
Pilots will be run in three different hospitals to test technologies and organisational changes. The project will facilitate the process of co-creation through living labs. An Innovation Hub will be launched. The project will deliver an Implementation Roadmap to multiply the innovations in other regions and initiate similar projects. Ultimately, the project has ambitions for outcomes with impact five and ten years after the project’s end.
What is Sensium’s role in the project?
The development areas for the Sensium system will see a new simple plug and play Home Bridge being designed and developed from scratch. Other developments will include the inclusion of an accelerometer to monitor the patient’s activity level.
Dr Alison Burdett, SENSIUM Chief Scientific Officer leading the SENSIUM element of the project had this to say:
“We are delighted to have been asked to participate in this very novel approach to delivering patient care. It really is an endorsement of our how robust our technology is that we were selected ahead of other providers as the preferred partner for this program.
This award will really help with our product enhancement activities as most of the product development effort required to satisfy this grant had already been identified as priority areas for SENSIUM in the next few years. The security that this grand funding now provides means that we can significantly accelerate our development into monitoring outside of a typical hospital environment.
This project will also allow us to get early clinical and new patient pathway feedback, as the final phase will see the new system being deployed in patients’ homes. Working with innovative leaders such as the Isala Clinic will mean that we can take this early experience and use it to help other forward-thinking hospitals to develop similar pathways, with the Sensium system as the key enabler.”
This project is co-funded by Interreg North-West Europe, under the European Regional Development Fund.
For more information visit the project website.
SENSIUM’s partners in the program include:
Isala Clinic (Netherlands), Jessa Ziekenhuis (Belgium), HC@Home (Netherlands), CE-Mate (Netherlands), European Health Telematics Association (Belgium), Universiteit Hasselt (Belgium), Digital Health and Care Institute (University of Strathclyde, UK), Maastricht University Medical Centre (Netherlands) , Build in Europe (Belgium).